Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · View financials
Decision snapshot: LUMN stock price vs ROIV: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ROIV's multiple
Needs ROIV P/S.
Implied fair value · at LUMN's multiple
Needs LUMN P/S.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: LUMN FY 2025 (ended Dec 31, 2025) · ROIV FY 2026 (ended Mar 31, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
LUMEN TECHNOLOGIES, INC. · implied price per share
Bear
$1.45
Base
$1.71
Bull
$1.96
ROIVANT SCIENCES LTD. · implied price per share
Bear
$4.51
Base
$5.30
Bull
$6.10
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-15.61x
0.10x
Net debt / EBITDA
Leverage against operating earnings
6.61x
32.78x
Cash and equivalents
Liquid reserves on the balance sheet
$1.00B
$4.29B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AT&T INC.
LUMN vs T
T-Mobile US, Inc.
LUMN vs TMUS
COMCAST CORP
LUMN vs CMCSA
CROWN CASTLE INC.
LUMN vs CCI
Revolution Medicines, Inc.
LUMN vs RVMD
INCYTE CORP
LUMN vs INCY
Sarepta Therapeutics, Inc.
LUMN vs SRPT
EXELIXIS, INC.
LUMN vs EXEL
VERTEX PHARMACEUTICALS INC / MA
LUMN vs VRTX
$17.44B
$442.59M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Price unavailable
Price unavailable
